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We have identified a novel, multiple spliced, subgenomic mRNA species in MMTV producing cells of different origin containing an open
reading frame encoding a 39-kDa Rev-like protein, Rem (regulator of expression of MMTV). An EGFP–Rem fusion protein is shown to be
predominantly in the nucleolus. Further leptomycin B inhibits the nuclear export of nonspliced MMTV transcripts, implicating Rem in
nuclear export by the Crm1 pathway in MMTV. Rem is thus reminiscent of the Rec protein from the related endogenous human retrovirus,
HERV-K.
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Mouse mammary tumor virus (MMTV) has been
classified as a simple retrovirus, associated with adenocar-
cinoma and T-cell lymphoma in mice. Unlike other simple
retroviruses which have only three open reading frames
(ORF) for structural (Gag, Env) and enzymatic (Pol)
proteins, MMTV encodes accessory/regulatory factors such
as Sag (Acha-Orbea and Palmer, 1991; Marrack et al., 1991)
and Naf (Salmons et al., 1990). Moreover, multiple addi-
tional promoters have been described in the MMTV genome
(Arroyo et al., 1997; Gunzburg et al., 1993; Miller et al.,
1992). HERV-K is an endogenous human retrovirus, related
to MMTV, and has been recently shown to encode Rec
(Lower et al., 1993, 1995), a functional homologue of Rev
and Rex of HIV and HTLV, respectively. The 14-kDa Rec
protein, encoded by a double spliced RNA, contains a
putative arginine-rich nuclear localization signal (NLS) and0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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pletely spliced and unspliced viral mRNAs, and enhances
their export to the cytoplasm. In contrast to HIV, where the
first Rev coding exon is located between pol and env, the
first Rec coding exon comprises nearly the entire signal
peptide of HERV-K Env. Interestingly, there is a striking
overall similarity between the Env regions of HERV-K and
MMTV, both in their hydrophobicity profiles, and in the
structure of their respective signal peptides. Moreover, the
signal peptides of both HERV-K and MMTV contain an
NLS (Hoch-Marchaim et al., 1998; Lower et al., 1995).
Here we report the identification of a novel, double spliced
MMTV transcript, analogous to Rec that encodes a
regulatory protein, Rem.Results
A novel double spliced MMTV-specific transcript
The MMTV-env gene was introduced into the expression
vector pcDNA3 between the CMV promoter and the bovine2005) 1 – 6
Rapid Communication2growth hormone polyadenylation site to generate an
MMTV-Env expression construct. Stable transfection of
the resulting plasmid, pCMVenv, into MMTV permissive
feline kidney cells, CrFK (Salmons et al., 1985) however,
did not result in detectable Env expression, although stable
transfection of a plasmid containing the complete MMTV
provirus did (Salmons et al., 1985). RT-PCR analysis of
mRNAs from pCMVenv transfected cells using primers
designed to detect envelope transcripts (Fig. 1A) did not
reveal the expected 2 kb fragment corresponding to the full-
length env RNA, but rather a smaller product of about 0.9
kb was reproducibly detected (Fig. 1B, lane 2). Sequencing
of the shorter product revealed that it results from a splicing
event. This intra-env splicing using the same splice donor
and acceptor sites has previously been described in mouse
T-lymphoma cells (EL-4) for a Sag encoding transcript
initiating from the promoter within the env gene (Miller
et al., 1992).
PCR using primers located in the CMV promoter and the
3V end of the env gene confirmed the presence of a complete
expression cassette in the stably transfected cells (data not
shown), suggesting that the vast majority of env RNA is
spliced in these cells and that this event is responsible for
the lack of Env protein expression.Fig. 1. (A) Schematic representation of the MMTV proviral genome is shown at t
and closed triangles indicate the locations of the splice donor sites. The arrows rep
RT-PCR. Using these primers a doubly spliced RNA species, in addition to env
8649R (lanes 1, 2, 3, 4, and 5); 1370F and 8649R (lanes 6, 7, and 8); 1370F and 98
was extracted from CrFK cells (lane 1, 5, 7, and 11); CrFK cells transfected by pCM
cells (4, 8, and 9). The sequencing of the product extracted from the agarose gelDouble spliced transcript is also present in MMTV-infected
cells
To determine whether this novel double spliced transcript
is biologically relevant, MMTV transcription was analyzed
in MMTV producer cells. RNA was extracted from CrFK
cells stably transfected with a complete, biologically active,
MMTV provirus (2C9), from nontransfected CrFK and from
mouse mammary tumor cells (GR) producing large amounts
of MMTV (Salmons et al., 1985). RT-PCR using the same
primers as above revealed two transcripts in GR and 2C9
cells but not in CrFK cells: the 2-kb product corresponding
to the full-length env message and the 0.9-kb product
resulting from the novel splicing event (Fig. 1B, lanes 3 and
4). In an attempt to identify the initiation site of the double
spliced transcript, we performed an RT-PCR with a primer
located in the U5 region of the LTR in combination with the
same env reverse primer (8649R). Two predominant
products of 2.3 kb and 1.1 kb were generated (Fig. 1B,
lanes 6 and 8) and sequencing confirmed that the longer
product represents the subgenomic env RNA transcript and
the smaller fragment arises from a double spliced RNA
species encoding an open reading frame. The intra-env
splicing was identical to that in pCMVenv transfected cells.he top. Open triangles indicate the locations of known splice acceptor sites,
resent the locations and orientations of the oligonucleotide primers used in
RNA, was identified. (B) RT-PCR was performed with primers 6684F and
77R (lanes 9, 10, ans 11); 935F and 8649R (lane 12). RNA used for RT-PCR
Venv expression vector (lane 2); GR cells (lanes 3, 6, 10, and 12) and 2C9
confirmed specificity of the reaction.
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3VLTR region since a specific product of just under 2.3 kb
was detected by RT-PCR performed with the U5 primer
in combination with a reverse primer which binds 7 nt
upstream of the MMTV polyadenylation signal (Fig. 1B,
lanes 9 and 10). No RT-PCR products could be detected
using a forward primer located immediately downstream
of the P2 cap site (Gunzburg et al., 1993) in combination
with the env reverse primer (Fig. 1B, lane 12). Taken
together these results suggest that the novel double
spliced RNA originates from the classic P1 promoter
(Fig 1B).
The first exon of the double spliced RNA is noncoding
and is shared with env RNA, while the second exon
comprises the entire signal peptide coding region and part of
the SU domain of Env. The third exon is common to the end
of the env mRNA (Fig 1A). This complex splicing pattern is
reminiscent of the splicing pattern of mRNA coding for
regulatory proteins in complex retroviruses, especially
HERV-K Rec (Lower et al., 1993).
The size of the double spliced viral RNA corresponds
to that previously detected by several groups in MMTV-
infected cells. Northern blots of RNA from virus-induced
mammary tumors in high tumor incidence strains of mice
revealed a message estimated as 2.5 kb after hybridization
with an env probe. The message contained LTR and
leader sequences and was proposed to be likely a splicing
product (Robertson and Varmus, 1981). A 2.5-kb MMTV
RNA species was also detected in MMTV-infected rat XC
and GR cells in addition to viral, nonspliced, genomic
transcript, and major subgenomic env RNA (Wheeler et
al., 1983). Moreover, an analogous doubly spliced RNA
species was detected in EL-4 T-cell lymphoma cells
(Racevskis, 1990).Fig. 2. (A) Deduced amino acid sequences of the putative protein encoded by the d
is underlined. The beginning of the MMTV SU is indicated by an arrow and gp52.
with dots above the letters. (B) Alignment of the first 100 amino acids of the putativ
acid as the reference strain BR6. Conserved putative NLS and NES domains are in
arginine (R in bold) rich NLS of the MMTV protein encoded by the double splic
Putative leucine (L in bold) rich NES of the MMTV protein encoded by doubleNovel 39-kDa protein encoded by MMTV
The newly identified ORF generated by the doubly
spliced transcript is 906 nt long and can potentially
encode a 34-kDa protein (Fig. 2A). Specific antiserum
was raised by immunizing rabbits with a synthetic peptide
(QRPHLALRRKRRREC) corresponding to a region from
the hydrophilic highly charged N-terminal part of the
putative protein. This polyclonal antiserum was then
employed to investigate expression of the putative protein
in vitro. A 39-kDa protein was detected specifically in
protein extracts from MMTV producing cells (2C9 and GR)
but not from their non-MMTV producing counterparts
(CrFK and NMuMG, respectively) (Fig. 3A). The presence
of two potential asparagine-linked glycosylation sites (Fig.
2A) allowing the attachment of two oligosaccharide units
(each with an average molecular mass of 2.5 kDa) to the
apoprotein may cause slower migration in the gel, giving
rise to a slightly larger protein (39 kDa) than that
predicted from the amino acid sequence (34 kDa).
MMTV 39-kDa protein carries putative NLS and NES motifs
Further analysis of the predicted amino acid sequence of
the 39 kDa protein revealed the presence of a highly basic
arginine-rich N-terminal region, which resembles the NLS
identified in the prototype lentiviral transactivator Rev of
HIV-1 (Malim et al., 1989) (Figs. 2A and C). This highly
basic region confers both specific RNA binding and nucleolar
localization to Rev. Another hallmark of the HIV-1 Rev is the
presence of a small leucine-rich motif (nuclear export signal,
NES) referred as to the Rev effector or activation domain.
This domain mediates the interaction between Rev and the
cellular cofactor, Crm1, thereby directing export of Rev fromouble spliced RNA. A putative NLS is marked in bold and the putative NES
Two potential N-glycosylation sites (NQT and NMS) are indicated by italics
e protein encoded by the double spliced RNA; dots indicate the same amino
dicated by the two rectangles, respectively. (C) Comparison of the putative
ed RNA with the NLS of HIV-1 Rev, HTLV-1 Rex, and HERV-K Rec. (D)
spliced RNA compared to the NES of the Rec, Rev, and Rex proteins.
Fig. 3. (A)Western blot analysis ofMMTV-bearing cells with an anti-peptide
antibody raised against the N-terminal arginine-rich region (putative nuclear
localization signal) of the protein encoded by the double spliced transcript.
NMuMG (lane 1), GR (lane 2), CrFK (lane 3), and 2C9 cells (lane 4) were
stimulated with dexamethasone and expression of the protein encoded by the
double spliced RNAwas detected. (B) Effect of LMB treatment on export of
MMTV transcripts from the nucleus. GR cells were stimulated with
dexamethasone and either treated or not treated with LMB, cytoplasmic
RNA prepared and analyzed by Northern blotting using an MMTV-LTR-
specific probe. Cytoplasmic RNA from MMTV producing GR mammary
cells not treated (lane 1) or treated (lane 2) with LMB are shown.
Rapid Communication4the nucleus (Malim et al., 1991). A similar leucine-rich
domain was also identified by analyzing the amino acid
sequence of the 39-kDaMMTV protein encoded by the novel
double spliced RNA (Figs. 2A and D). Both the putative NLS
and NESmotifs are highly conserved between various strains
of MMTV (Fig. 2B) suggesting their functional relevance.
The closely related beta-retrovirus HERV-K also exhibits a
complex splicing pattern and the Rec protein, encoded by a
double spliced RNA, carries NLS and NES consensus
sequences suggesting that this protein shuttles between the
nucleus and cytoplasm of the cell. We propose that the 39-
kDa protein we have identified is the MMTV homolog of
HERV-K Rec and thus HIV-1 Rev and HTLV Rex. Therefore
we have called this protein Rem for regulator of expression of
MMTV.Fig. 4. Intracellular distribution of the EGFP–Rem fusion protein. CrFK cells were
E–H) encoding an EGFP–Rem fusion protein and nucleoli were visualized by ind
conjugated secondary antibody. Shown are images of the transfected cells under p
and F), or RPE fluorescence (panels C and G) as well as an overlay (merged image)
400.A fusion EGFP–Rem protein is localized within the nucleoli
To investigate intracellular distribution of Rem, cells
were transfected with the plasmid pEGFP–Rem encoding
Rem fused to the enhanced green fluorescent protein
(EGFP). The EGFP–Rem fusion protein was predominantly
localized in the nucleoli of cells (Fig. 4, panel F), but minor
levels of the fusion protein were also present in the
cytoplasm. In contrast, cells transfected with an EGFP
expression vector (pEGFP–C1) without the Rem fusion
(Fig. 4, panel B) or with a fusion plasmid encoding Rem in
the antisense orientation (data not shown) showed a
cytoplasmic distribution of EGFP. Immunocytochemistry
with a red-fluorescence-coupled antibody directed against
nucleophosmin (also known as nucleolar phosphoprotein
B23) was performed (Fig. 4, panels C and G). Overlay of
these images with the corresponding EGFP data reveals the
colocalization of EGFP–Rem (Fig. 4, panel H) but not
EGFP (Fig. 4, panel D) with nucleophosmin thereby
confirming a mainly nucleolar localization of the fusion
protein. Together, these data confirm that Rem contains a
functional NLS and that its subcellular nucleo-cytoplasmic
localization is similar to the localization of the Rec and Rev
proteins (Lower et al., 1995; Wolff et al., 1997). The
predominant nucleolar localization of the EGFP–Rem
fusion protein is reproducibly observed in various murine
(NMuMG), human (293, HeLa), and feline (CrFK) cells
(not shown), suggesting that this localization is not a cell-
specific property.
Export of MMTV nonspliced, genomic RNA is Crm1
dependent
The Rec protein of HERV-K, like Rev of HIV-1,
mediates the export of nonspliced viral RNAs through its
interaction with the nuclear export factor, Crm1. This
interaction can be specifically blocked by the antibiotictransfected with either pEGFP–C1 (panels A–D) or pEGFP–Rem (panels
irect immunostaining with anti-nucleophosmin antibody followed by RPE-
hase contrast (panels A and E), UV to reveal EGFP fluorescence (panels B
of EGFP and the nucleophosmin images (panels D and H). Magnification is
Rapid Communication 5leptomycin B (LMB), which traps the Rec or Rev protein in
the nucleus and thus inhibits export of nonspliced RNAs
(Wolff et al., 1997). To investigate whether export of
nonspliced MMTV RNA also proceeds through an LMB
sensitive Crm1-dependent pathway, GR cells were treated
with the antibiotic, cytoplasmic RNA harvested 14 h later,
and a Northern blot was performed. Non-LMB-treated GR
cells produce a 8.6-kb nonspliced transcript as well as the
3.8-kb env RNA and the 2.5-kb transcript, corresponding to
RT-PCR product in Fig. 1. Treatment of these cells with
LMB results in a loss of detection of the 8.6-kb nonspliced
transcript and an increase in the levels of the 2.5-kb
transcript. These data further support the notion that export
of nonspliced MMTV mRNA from the nucleus is Crm1
dependent.Discussion
In this communication we demonstrate that expression of
MMTV from GR and 2C9 cells results in a complex pattern
of mRNA species including a novel doubly spliced tran-
script with an ORF with the potential to encode for an
auxiliary protein containing amino acid motifs which
resemble the nuclear localization and export signals of the
viral regulatory proteins Rev of HIV and Rec of HERV-K.
Using an antiserum raised against a peptide from the
putative hydrophilic region of the predicted protein, a 39-
kDa protein was observed in two MMTV-producing cell
lines (GR and 2C9). To our knowledge, this protein is larger
than all known Rev-like proteins (for instance 14 kDa Rec
of HERV-K, 19 kDa Rev of HIV-1, and 27 kDa Rex of
HTLV-1). Hoch-Marchaim and coworkers also raised an
antiserum against the same peptide from the leader peptide
region and detected two smaller nucleolar proteins, p14 and
p21, specifically in MMTV-bearing T-cell lymphomas but
not in MMTV-infected mammary tumors or derived cell
lines (Hoch-Marchaim et al., 1998). Similar to these authors,
we could not detect p14 or p21 in GR cells which are
derived from an MMTV induced mammary carcinoma or
the productively transfected 2C9 cells (Salmons et al.,
1985). At present, it cannot be excluded that the 39-kDa
protein detected in both GR and 2C9 cells is further
processed and what effect, if any, this would have on its
activity. In this light, it is intriguing that p14 expressed in a
several MMTV-derived T-cell lymphomas co-immunopre-
cipitated and co-localized with the nucleolar phosphoprotein
B23, a protein known to interact with HIV Rev and HTLV
Rex proteins (Hoch-Marchaim et al., 2003).
Analogous to Rev or Rec, Rem is expressed from a doubly
spliced viral transcript and possesses a putative NLS that
mediates nuclear import which is inextricably linked with
nucleolar localization (Hope et al., 1990). Here we demon-
strate that Rem fused to cytoplasmic EGFP is predominantly
localized in the nucleolus, indicating efficient nuclear import
of the fusion protein and accumulation in the nucleoli.Similarly, nucleolar accumulation of Rec and Rev was indeed
reported for HERV-K and HIV, respectively (Lower et al.,
1995; Wolff et al., 1997). In analogy to Rev and Rec, low
levels of Rem were also present in the cytoplasm.
Another characteristic feature of retroviruses that regulate
nuclear export of viral RNA via the Crm1 rather than the
Tap1 pathway is sensitivity to inhibition by LMB. This low-
molecular-weight antibiotic specifically blocks NES-
dependent RNA export. In contrast, cytoplasmic accumu-
lation of RNA containing the constitutive transport element
(CTE) of Mason–Pfizer monkey virus or another cis-acting
RNA export element, termed the posttranscriptional regu-
latory element (RTE), is not inhibited by LMB treatment
(Otero et al., 1998). We hypothesized that although Rem
contains a consensus NES, its function requires Crm1 and
thus the nuclear export of nonspliced MMTV RNA would
be inhibited by LMB. Indeed, LMB treatment of MMTV
producing mammary cells resulted in an almost complete
loss of nonspliced transcript in the cytoplasm of these cells.
To our knowledge this is the first demonstration that the
nuclear export of the MMTV full-length transcript requires
the Crm1 pathway.
The finding that MMTV encodes a novel protein, Rem,
associated with post-transcriptional RNA export adds yet
another level of complexity to this betaretrovirus. It remains
to be determined what effect, if any, Rem has on spliced
transcripts such as those encoding Sag or Naf.Materials and methods
Plasmid constructions
The plasmid pCMVenv was constructed by inserting the
env ORF into the HindIII–XbaI digested expression vector
plasmid, pcDNA3 (Invitrogen). The plasmid pEGFP–Rem
was constructed by inserting full-length ORF encoded by
double spliced transcript in-frame into the BamHI-digested
pEGFP–C1 vector (Clontech). The same ORF was also
inserted into pEGFP–C1 vector in anti-sense orientation,
creating pEGFP–Rem-anti plasmid.
Transfections
Transfection of 3 Ag of the respective plasmid was
performed in six-well plates using the calcium phosphate
method. Stably transfected cells selected in medium con-
taining 400 Ag/ml were used for further analysis.
Western blot
Cell monolayers were washed with cold PBS and lysed
in buffer (10 mM Tris–HCl, 140 mM NaCl, 1% Triton X-
100, 1 mM PMSF). The lysate was clarified by low speed
centrifugation and protein concentration measured (Bio-Rad
DC Protein assay). 20 Ag of total protein was separated on
Rapid Communication6SDS–polyacrylamide gels and transferred to PDVF mem-
branes. Antipeptide serum raised against the peptide
QRPHLALRRKRRREC (Genosphere Biotechnologies)
was used for detection of the Rem protein in cell lysates.
Cytoplasmic RNA extraction and Northern blot
Expression of MMTV proteins was stimulated by adding
106 M dexamethasone and at the same time 10 nM
leptomycin B was added to the culture medium for 14 h.
Cytoplasmic RNA was then extracted (using an RNeasy
Mini kit, Qiagen) according to the manufacturer’s instruc-
tions and 3 Ag applied to a 1.2% agarose gel. After blotting
onto a nylon membrane, the filter was probed with a DIG-
labeled MMTV-LTR-specific RNA. The probe was prepared
by in vitro transcription of the PCR product using a Roche





Total cellular RNA was used as a template for RT-PCR.
Reverse transcription with MMTV-specific reverse primer
(8649R: 5V-GTGTAGGACACTCTCGGGAGTTC-3V,
9877R: 5V-TCAGCACTCTTTTATATT-3V) was performed
according to manufacturer’s instructions (Superscript II Re-
verse Transcriptase, Invitrogen). In the next step, RNA
complementary to the cDNA was removed by RNaseH
digestion and PCR was carried out with the same reverse
primer in combination with appropriate forward primer
(935F: 5V-AAGACGACATGAAACAACAG-3V, 1370F: 5V-
CGTCTCCGCTCGTCACTTAT-3V, 6684F: 5V-ATGCC-
GAAACACCAATCTG-3V). Specificity of the PCR was
confirmed by direct sequencing of PCR products in both
directions.
Fluorescence microscopy
CrFK cells transfected with pEGFP–C1 or pEGFP–Rem
plasmid were fixed by 2% formaldehyde in PBS for 5 min
and permeabilized in 0.2% Triton X-100 in PBS for 20 min.
Then, cells were blocked in PBS containing 1% BSA for 1 h
at room temperature and immunostained with anti-nucleo-
phosmin monoclonal antibody (Sigma) for 1 h at room
temperature followed by incubating with RPE-conjugated
anti-mouse secondary antibody (Dako) for another 1 h.
After mounting, cells were observed in a Carl Zeiss
Axiovert 200M UV microscope.Acknowledgment
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